Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-01-05 @ 12:01 PM
Study NCT ID:
NCT05089656
Status:
COMPLETED
Last Update Posted:
2025-12-08
First Post:
2021-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-29
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-11
First Submit QC Date:
None
Study First Post Date:
2021-10-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-10-27
Results First Submit QC Date:
None
Results First Post Date:
2025-12-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-12-08
Last Update Post Date Type:
ESTIMATED